Steward Partners Investment Advisory LLC Has $276,000 Position in ARK Genomic Revolution ETF (BATS:ARKG)

Steward Partners Investment Advisory LLC cut its position in ARK Genomic Revolution ETF (BATS:ARKG) by 20.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,719 shares of the company’s stock after selling 2,957 shares during the quarter. Steward Partners Investment Advisory LLC’s holdings in ARK Genomic Revolution ETF were worth $276,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in ARKG. JPMorgan Chase & Co. increased its position in ARK Genomic Revolution ETF by 31.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,955,279 shares of the company’s stock worth $75,655,000 after purchasing an additional 698,701 shares in the last quarter. Barclays PLC increased its position in ARK Genomic Revolution ETF by 252.7% during the 3rd quarter. Barclays PLC now owns 285,108 shares of the company’s stock worth $7,299,000 after purchasing an additional 204,283 shares in the last quarter. PFM Health Sciences LP acquired a new position in ARK Genomic Revolution ETF during the 3rd quarter worth approximately $2,226,000. Quadrature Capital Ltd acquired a new position in ARK Genomic Revolution ETF during the 3rd quarter worth approximately $1,970,000. Finally, Tallon Kerry Patrick acquired a new position in ARK Genomic Revolution ETF during the 4th quarter worth approximately $637,000.

ARK Genomic Revolution ETF Trading Down 3.6 %

ARKG stock opened at $22.76 on Friday. The company has a 50 day simple moving average of $25.75 and a 200 day simple moving average of $25.18. ARK Genomic Revolution ETF has a 1 year low of $21.56 and a 1 year high of $31.16.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.